MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last?

Most New 2024 Biopharma Offerings Trade Lower Later

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.